ROLE OF ALLELIC VARIANTS OF FK506-BINDING PROTEIN 51 (FKBP5) GENE IN THE DEVELOPMENT OF ANXIETY DISORDERS: FKBP5 Gene and Affective Disorders
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Anxiety disorders exhibit remarkably high rates of comorbidity with major depressive disorder (MDD). Mood and anxiety disorders are considered stress-related diseases. Genetic variations in the co-chaperone FK506-binding protein 51, FKBP5, which modulates the function of glucocorticoid receptors, have been associated with an increased risk for the development of posttraumatic stress disorder, but data regarding its role in MDD are controversial. The aims of this study were to clarify the role of the FKBP5 gene in depression and anxiety disorders through a case-control study and an association study with personality traits using the Temperament and Character Inventory (TCI) in healthy subjects. METHODS: Six hundred fifty-seven MDD patients, with or without an anxiety disorder in comorbidity, and 462 healthy volunteers were enrolled in the study. Two hundred fifty-six controls agreed to fill out the TCI. RESULTS: The results showed that the T allele of rs1360780 was more frequent among the patients affected by MDD with a comorbidity of anxiety disorders, compared to those without (P < .001). Among the controls, we found that the T allele more often exhibited personality traits associated with an increased vulnerability to anxiety. CONCLUSIONS: These results support the hypothesis that allelic variants of FKBP5 are a risk factor for anxiety disorders. The identification of genetic variants involved in anxiety may have implications for the optimization of therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Binder, E. B. (2008) · JAMA · doi:10.1001/jama.299.11.1291 · Cited by 1,362
Sample Size Requirements for Estimating Pearson, Kendall and Spearman Correlations
Bonett, D. G., & Wright, T. A. (2000) · Psychometrika · doi:10.1007/bf02294183 · Cited by 1,095 · cited 1×
“[26] Since the size of both samples is sufficiently large (n > 100),[27]”
BackgroundGenes, evolution, and personality
Bouchard, T. J., & Loehlin, J. C. (2001) · Behavior Genetics · doi:10.1023/a:1012294324713 · Cited by 1,085 · cited 1×
“In particular, temperament dimensions are highly heritable and stable throughout life and are correlated with emotional reactions and habits[20] and according to the literature, approximately 30–60% of the variance in personality traits is due to genetic factors.[21] Regarding personality traits, only one study is pre…”
BackgroundBinder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977 · cited 2×
“Binder and colleagues[11] reported that the number of depressive episodes was increased among MDD patients with the TT genotype of rs1360780, and Lekman[35] previously showed a significant overrepresentation of the T allele in MDD.”
BackgroundBinder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968 · cited 2×
“A prolonged or excessive activation of this system has been implicated in the pathogenesis of depressive and anxiety disorders, involving an impaired sensitivity of glucocorticoid receptors (GRs).[6] GRs are intracellular receptors that translocate from the cytosol to the nucleus after ligand binding to regulate gene…”
BackgroundFava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927
Wochnik, G. M., Rüegg, J., Abel, G. A., Schmidt, U., Holsboer, F., & Rein, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407498200 · Cited by 638
The glucocorticoid responses are shaped by molecular chaperones
Grad, I., & Picard, D. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.018 · Cited by 423 · cited 3×
“The heat shock protein 90 co-chaperone FK506-binding protein 51, encoded by the FKBP5 gene on chromosome 6, represents a crucial regulator of GRs[7] that is able to decrease the affinity of GRs for their ligands;[8] FKBP5 expression is in turn regulated by glucocorticoids.”
BackgroundStatus of Glucocorticoid Alterations in Post‐traumatic Stress Disorder
Yehuda, R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04979.x · Cited by 409 · cited 2×
“This finding was replicated in another study,[15] and it has also been demonstrated that FKBP5 is less expressed in individuals with current PTSD.[16] A recent review[17] indicated that MDD is correlated with anxiety disorders and this is partially supported by data from family studies.”
ResultInteraction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder
Xie, P., Kranzler, H. R., Poling, J., Stein, M. B., Anton, R. F., Farrer, L. A., & Gelernter, J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.37 · Cited by 327 · cited 1×
“This finding was replicated in another study,[15] and it has also been demonstrated that FKBP5 is less expressed in individuals with current PTSD.”
ResultVermeer, H., Hendriks-Stegeman, B. I., van der Burg, B., van Buul-Offers, S. C., & Jansen, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020354 · Cited by 285 · cited 2×
“To explain the possible role played by FKBP5 genetic variants in anxiety, we should consider the modulatory effect of FKBP5 on GR sensitivity and nuclear translocation,[8] together with the regulation exerted by glucocorticoids on its expression as part of an intracellular negative feedback pathway regulating GR activ…”
BackgroundLekman, M., Laje, G., Charney, D., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Lipsky, R., Wisniewski, S. R., Manji, H., McMahon, F. J., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.026 · Cited by 284 · cited 1×
“Binder and colleagues[11] reported that the number of depressive episodes was increased among MDD patients with the TT genotype of rs1360780, and Lekman[35] previously showed a significant overrepresentation of the T allele in MDD.”
BackgroundWhat is the genetic relationship between anxiety and depression?
Hettema, J. M. (2008) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30171 · Cited by 207 · cited 2×
“[16] A recent review[17] indicated that MDD is correlated with anxiety disorders and this is partially supported by data from family studies.”
BackgroundResultIntronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids
Hubler, T. R., & Scammell, J. G. (2004) · Cell Stress & Chaperones · doi:10.1379/csc-32r.1 · Cited by 201
Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks
Sarapas, C., Cai, G., Bierer, L. M., Golier, J. A., Galea, S., Ising, M., Rein, T., Schmeidler, J., Müller-Myhsok, B., Uhr, M., et al. (2011) · Disease Markers · doi:10.1155/2011/328054 · Cited by 143
Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks
Sarapas (2011) · PubMed · doi:10.3233/dma-2011-0764 · Cited by 143
Ceulemans, S., De Zutter, S., Heyrman, L., Norrback, K., Nordin, A., Nilsson, L., Adolfsson, R., Del‐Favero, J., & Claes, S. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00960.x · Cited by 22 · cited 1×
“[10] Genetic studies of depression have suggested a role for FKBP5 in this disease and in antidepressant response, but these data are largely contradictory;[11–13] more convincing evidence is available for its involvement in anxiety disorders.”
Background
Cited by
Gene–Stress–Epigenetic regulation of FKBP5: clinical and translational implications
Zannas, A. S., Wiechmann, T., Gassen, N. C., & Binder, E. B. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.235 · Cited by 622
“…risk for relapse and recurrent course of MDD and PTSD (Binder et al, 2004; Wilker et al, 2014), maladaptive personality traits and attitudes (Minelli et al, 2013; Shibuya et al, 2010; Suzuki et al, 2014), worse cognitive performance (Fujii et al, 2014b), and higher risk for bipolar disorder…”
BackgroundFerrer, A., Costas, J., Labad, J., Salvat-Pujol, N., Segalàs, C., Urretavizcaya, M., Real, E., de Arriba-Arnau, A., Alonso, P., Crespo, J. M., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.08.003 · Cited by 35
Kelly, M. M., Jensen, K. P., & Sofuoglu, M. (2015) · The American Journal on Addictions · doi:10.1111/ajad.12304 · Cited by 23
FKBP5 interacts with maltreatment in children with extreme, pervasive, and persistent aggression
Bryushkova, L., Zai, C., Chen, S., Pappa, I., Mileva, V., Tiemeier, H., Bakermans-Kranenburg, M., Kennedy, J. L., & Beitchman, J. H. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2015.09.052 · Cited by 13
A precision medicine approach to pharmacological adjuncts to extinction: A call to broaden research
King, G., Baker, K. D., Bisby, M. A., Chan, D., Cowan, C. S. M., Stylianakis, A. A., Zimmermann, K. S., & Richardson, R. (2019) · Psychopharmacology · doi:10.1007/s00213-018-4999-0 · Cited by 6
Metadata
- Authors
- Minelli, A., Maffioletti, E., Cloninger, C. R., Magri, C., Sartori, R., Bortolomasi, M., Congiu, C., Bignotti, S., Segala, M., Giacopuzzi, M., & Gennarelli, M.
- Venue
- Depression and Anxiety
- Publisher
- Hindawi Limited
- Published
- 2013-07-16
- Volume
- 30
- Issue
- 12
- Pages
- 1170-1176
- ISSN
- 1091-4269 (ISSN-L)
- OpenAlex
- W1547844731
- Cited by
- 52
- References
- 17
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.